PCC Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in DeLisle, MS Along the U.S. Gulf Coast

The Chemours Company (Chemours) (NYSE: CC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO₂) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210379532/en/

“Today, Chemours Titanium Technologies takes an important step in its continued operational excellence transformation, under Pathway to Thrive, partnering with the PCC Group to gain increased supply reliability through on-site chlorine at our DeLisle TiO₂ facility,” said Denise Dignam, President and CEO of Chemours. “This new partnership, requiring no up-front financial commitment from Chemours, will enable us to lower our manufacturing costs and better serve our customers as their trusted TiO₂ partner of choice. It also reinforces our commitment to the Mississippi Gulf Coast community we have called home for nearly 45 years.”

“Our partnership with Chemours exemplifies PCC Group’s commitment to grow in chemicals by building upon long-term relationships,” said Peter Wenzel, CEO, PCC SE. “We are dedicated to using our decades-long experience to safely and responsibly extend our chemical business at this facility. We look forward to a successful collaboration with such a major, globally renowned player as Chemours, setting a benchmark in the industry while evaluating further opportunities in the region.”

The project will create full-time opportunities for skilled personnel with PCC, and up to 1,200 temporary construction jobs.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,100 employees and 28 manufacturing sites and serves approximately 2,700 customers in approximately 110 countries.

For more information, visit chemours.com or follow us on X (formerly Twitter) @Chemours or LinkedIn.

About PCC SE

Headquartered in Duisburg, Germany, PCC SE is the parent and investment holding company of the globally active PCC Group with around 3,300 employees. Its Group companies have core competencies in the production of chemical feed stocks and specialty chemicals, silicon and silicon derivatives, and in container logistics. An investor committed to the longer term, PCC SE concentrates on continuously increasing the enterprise value of its portfolio companies through sustainable investments and the ongoing creation of new value. The largest chemical producers of the PCC Group are PCC Rokita SA, a major chlorine manufacturer and Eastern Europe's leading producer of polyols, and PCC Exol SA, one of Europe's most advanced surfactant manufacturers. PCC BakkiSilicon hf. operates in Iceland one of the world's most advanced and climate-friendly silicon production facilities. PCC was founded in 1993 by Waldemar Preussner, sole shareholder of PCC SE, who today holds the position of Chairman of the Supervisory Board. For further information on PCC, go to: https://www.pcc.eu.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, estimated operation date, ability to ensure reliability, anticipated production capacity, anticipated future operating and financial performance for our segments individually and our company as a whole, capital investments and projects and target capital expenditures, cost reductions or savings targets, plans to increase profitability and growth, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241210379532/en/